慢性病中的红素诱导高血压 - - 一个机理性随机对照试验
1Richard L. Roudebush VA Medical Center, Indiana University, Indianapolis, Indiana, USA.
American journal of hypertension
|October 6, 2025
概括
红素刺激剂 (ESAs) 在贫血慢性病 (CKD) 患者中没有显著改变血压. 然而,达比波丁的使用与白色素尿和不良事件的增加有关,这需要进一步调查.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性病 (CKD) 患者的高血压在接受红色素刺激剂 (ESA) 治疗时具有复杂且不太了解的机制.
- 贫血是常见的CKD患者,通常是用ESAs治疗.
研究的目的:
- 为了研究 darbepoetin 对贫血高血压慢性结核病患者的血压和内皮功能的影响.
- 评估darepoetin在这个患者群体中的安全性.
主要方法:
- 一项随机对照试验,涉及贫血高血压慢性病患者,血压控制.
- 患者被分配到等待名单上的组或以1:1的比例接受达比波丁.
- 主要终点是从基线到12周的24小时舒张门诊血压的变化.
主要成果:
- 与等待名单组相比,达尔贝波丁治疗导致血红蛋白在1.7g/dL的差异.
- 两组之间24小时的门诊血压变化没有显著差异 (差异为2.98 mmHg).
- 在等待名单组中,在达比波丁暴露期间,白尿增加了35%,而严重的不良事件在达比波丁时更频繁.
结论:
- 达尔贝波丁在有控制高血压的贫血慢性结核病患者中没有显著改变24小时的门诊血压或内皮功能.
- 在达伯波丁暴露期间观察到的白尿增加和不良事件令人担忧,需要进行更大规模的研究来确认.
更多相关视频
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
676
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
24.3K
相关概念视频
01:18Hypertension and Regulation of Blood Pressure
3.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
01:17Hormonal Regulation of Blood Pressure
5.9K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.9K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:29Hypertension II: Pathophysiology
787
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
787
01:25Chronic Kidney Disease I: Introduction
560
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
560
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K